[
    {
        "id": 1,
        "text": "1.一個pKa為3.4的酸性藥品，在胃部（pH 1.4）和血漿中（pH 7.4）非離子態（unionized form）的比例於平衡時約為多少？",
        "options": {
            "A": "10000：1",
            "B": "1000：1",
            "C": "100：1",
            "D": "1：1"
        },
        "image": null
    },
    {
        "id": 2,
        "text": "2.下列有關消化道投藥的敘述，何者正確？",
        "options": {
            "A": "動物完全無法使用舌下投藥",
            "B": "誘導關閉牛隻的食道溝，會使藥品停留在食道上部",
            "C": "首渡效應常使口服利用率增加",
            "D": "直腸投藥可減少首渡效應的影響"
        },
        "image": null
    },
    {
        "id": 3,
        "text": "3.偏鹼性藥品在乳汁中的濃度會較其在血中為高的原因為何？",
        "options": {
            "A": "因脂溶性較高而使得吸收速率較快",
            "B": "因多會被主動運輸（active transport）運送進入",
            "C": "因可和乳汁中的兩價離子結合",
            "D": "因會產生離子捕捉（ion-trapping）的現象"
        },
        "image": null
    },
    {
        "id": 4,
        "text": "4.下列有關血漿蛋白結合（plasma protein binding）的敘述，何者正確？",
        "options": {
            "A": "所有sulfonamides的血漿蛋白結合率皆相似",
            "B": "解離常數（dissociation constant）愈小者結合力愈弱",
            "C": "Phenylbutazone與warfarin可相互競爭血漿蛋白結合",
            "D": "Digitoxin主要和球蛋白結合"
        },
        "image": null
    },
    {
        "id": 5,
        "text": "5.下列有關抑制「酶」與其作用的敘述，何者錯誤？",
        "options": {
            "A": "抑制cyclooxygenase可抑制前列腺素的合成",
            "B": "抑制phosphodiesterase可增加心臟收縮力",
            "C": "抑制β-lactamase可增加抗黴菌劑的藥效",
            "D": "抑制DNA gyrase可具有殺菌藥效"
        },
        "image": null
    },
    {
        "id": 6,
        "text": "6.下列何藥品對CYP-450的作用和其他三個藥品不同？",
        "options": {
            "A": "chloramphenicol",
            "B": "ketoconazole",
            "C": "primidone",
            "D": "cimetidine"
        },
        "image": null
    },
    {
        "id": 7,
        "text": "7.下列何者是造成犬隻經口投予lidocaine生體可用率（bioavailability）不佳的主因？",
        "options": {
            "A": "因具有四級銨的結構而降低吸收",
            "B": "因會和食物中的二價離子螯合",
            "C": "因肝臟代謝速率快",
            "D": "因無法經由腎臟再吸收"
        },
        "image": null
    },
    {
        "id": 8,
        "text": "8.下列何種併用較不會產生藥品不良反應（adverse drug reaction）？",
        "options": {
            "A": "phenylbutazone與coumarins",
            "B": "furosemide與digitalis",
            "C": "clavulanic acid與amoxicillin",
            "D": "streptomycin與amphotericin B"
        },
        "image": null
    },
    {
        "id": 9,
        "text": "9.下列何者可以由Henderson-Hasselbalch方程式運算得到？",
        "options": {
            "A": "藥物於不同pH值水溶液中的解離比率",
            "B": "藥物於不同pH值水溶液中的水解速率",
            "C": "藥物於不同pH值水溶液中的代謝速率",
            "D": "藥物於不同pH值水溶液中的溶解度"
        },
        "image": null
    },
    {
        "id": 10,
        "text": "10.下列何者是犬隻使用thiopental麻醉作用時間短暫的主要原因？",
        "options": {
            "A": "藥物很快被腎臟排除",
            "B": "藥物於不同組織間的重分布",
            "C": "藥物很快被肝臟代謝",
            "D": "藥物與血漿蛋白結合比率極高"
        },
        "image": null
    },
    {
        "id": 11,
        "text": "11.Epinephrine升高血壓的作用與propranolol降低血壓的作用屬於下列何種拮抗？",
        "options": {
            "A": "受體拮抗（receptor antagonism）",
            "B": "生理拮抗（physiologic antagonism）",
            "C": "化學拮抗（chemical antagonism）",
            "D": "酵素拮抗（enzymatic antagonism）"
        },
        "image": null
    },
    {
        "id": 12,
        "text": "12.藥物在豬的生物轉化（biotransformation），下列何者較容易被飽和？",
        "options": {
            "A": "acetylation",
            "B": "amino acid conjugation",
            "C": "sulfate conjugation",
            "D": "glucuronidation"
        },
        "image": null
    },
    {
        "id": 13,
        "text": "13.下列何者是藥物動力學計算的參數？",
        "options": {
            "A": "藥物與受體之親和力",
            "B": "藥物之最大生理效應",
            "C": "藥物之相對效價",
            "D": "藥物吸收速率及程度"
        },
        "image": null
    },
    {
        "id": 14,
        "text": "14.臨床上，diprenorphine適合做為下列那一藥物之拮抗劑？",
        "options": {
            "A": "diazepam",
            "B": "etorphine",
            "C": "ketamine",
            "D": "xylazine"
        },
        "image": null
    },
    {
        "id": 15,
        "text": "15.下列有關競爭性神經肌肉阻斷藥物之敘述，何者錯誤？",
        "options": {
            "A": "Tubocurarine在狗和貓不會引起histamine釋放",
            "B": "Pancuronium引起心跳速率的輕微增加",
            "C": "Atracurium可誘發histamine釋放",
            "D": "Vecuronium具有競爭乙醯膽鹼受器的作用"
        },
        "image": null
    },
    {
        "id": 16,
        "text": "16.下列何者可作為競爭性神經肌肉阻斷劑中毒的解毒劑？",
        "options": {
            "A": "MAO inhibitors",
            "B": "acetylcholinesterase inhibitors",
            "C": "COMT inhibitors",
            "D": "COX inhibitors"
        },
        "image": null
    },
    {
        "id": 17,
        "text": "17.下列何者最適合使用於患有肝、腎疾病動物之麻醉？",
        "options": {
            "A": "halothane",
            "B": "isoflurane",
            "C": "methoxyflurane",
            "D": "pentobarbital"
        },
        "image": null
    },
    {
        "id": 18,
        "text": "18.下列何者是蕈毒鹼性致效劑，且投予後可直接與蕈毒鹼性受體結合產生作用？",
        "options": {
            "A": "neostigmine",
            "B": "echothiophate",
            "C": "hyoscyamine",
            "D": "bethanechol"
        },
        "image": null
    },
    {
        "id": 19,
        "text": "19.下列何者主要活化β2-腎上腺素性受體，藉此舒張支氣管？",
        "options": {
            "A": "dobutamine",
            "B": "hyoscyamine",
            "C": "salmeterol",
            "D": "atipamezole"
        },
        "image": null
    },
    {
        "id": 20,
        "text": "20.下列何者為選擇性β1-腎上腺素性受體拮抗劑？",
        "options": {
            "A": "albuterol",
            "B": "metaraminol",
            "C": "atenolol",
            "D": "atipamezole"
        },
        "image": null
    },
    {
        "id": 21,
        "text": "21.下列何者是選擇性的α1-腎上腺素性受體致效劑？",
        "options": {
            "A": "bretylium",
            "B": "phenoxybenzamine",
            "C": "phenylephrine",
            "D": "prazosin"
        },
        "image": null
    },
    {
        "id": 22,
        "text": "22.下列何者為臨床經口投予prazosin之主要目的？",
        "options": {
            "A": "興奮中樞神經系統",
            "B": "鎮靜及鬆弛肌肉",
            "C": "增加心輸出量",
            "D": "促進脂肪分解速率"
        },
        "image": null
    },
    {
        "id": 23,
        "text": "23.長期使用利尿劑後，常發生低血壓性反射作用而引起心律不整，可併用何種藥物改善？",
        "options": {
            "A": "α1 blocker",
            "B": "α2 blocker",
            "C": "β1 blocker",
            "D": "β2 blocker"
        },
        "image": null
    },
    {
        "id": 24,
        "text": "24.Enoxaparin對下列何種凝血因子的抑制作用最強？",
        "options": {
            "A": "II",
            "B": "XI",
            "C": "X",
            "D": "IX"
        },
        "image": null
    },
    {
        "id": 25,
        "text": "25.下列何者最適合使用於加強鬱血性心衰竭心肌之收縮力量？",
        "options": {
            "A": "hydralazine",
            "B": "amrinone",
            "C": "nitroglycerin",
            "D": "doxapram"
        },
        "image": null
    },
    {
        "id": 26,
        "text": "26.下列何者為使用lidocaine抗心律不整之主要作用機制？",
        "options": {
            "A": "縮短心肌動作電位期間",
            "B": "阻斷Ca++離子通道",
            "C": "縮短動作電位之不反應期",
            "D": "增加迷走神經之張力"
        },
        "image": null
    },
    {
        "id": 27,
        "text": "27.下列何者利尿劑因可增加前部遠曲小管鈣的吸收、降低尿鈣的排出，因而可用來治療草酸鈣尿路結石？",
        "options": {
            "A": "ethacrynic acid",
            "B": "spironolactone",
            "C": "triamterene",
            "D": "hydrochlorothiazide"
        },
        "image": null
    },
    {
        "id": 28,
        "text": "28.下列藥物何者不具有抗高血鉀症的特性？",
        "options": {
            "A": "spironolactone",
            "B": "insulin",
            "C": "furosemide",
            "D": "hydrochlorothiazide"
        },
        "image": null
    },
    {
        "id": 29,
        "text": "29.下列何者兼具利尿和矯正代謝性鹼中毒的作用？",
        "options": {
            "A": "furosemide",
            "B": "amiloride",
            "C": "acetazolamide",
            "D": "spironolactone"
        },
        "image": null
    },
    {
        "id": 30,
        "text": "30.下列有關ammonium chloride的作用，何者錯誤？",
        "options": {
            "A": "酸化尿液",
            "B": "利尿作用",
            "C": "祛痰作用",
            "D": "止吐作用"
        },
        "image": null
    },
    {
        "id": 31,
        "text": "31.下列影響腸胃功能的藥物中，何者最可能會干擾其他同時口服藥物的吸收？",
        "options": {
            "A": "cimetidine",
            "B": "misoprostol",
            "C": "omeprazole",
            "D": "sucralfate"
        },
        "image": null
    },
    {
        "id": 32,
        "text": "32.下列何者具有促進胃黏膜分泌黏液質的作用？",
        "options": {
            "A": "meclizine",
            "B": "methadone",
            "C": "metoclopramide",
            "D": "misoprostol"
        },
        "image": null
    },
    {
        "id": 33,
        "text": "33.下列腸胃道用藥中，何者在重複給藥後，會累積於胃壁細胞中？",
        "options": {
            "A": "misoprostol",
            "B": "omeprazole",
            "C": "ranitidine",
            "D": "sucralfate"
        },
        "image": null
    },
    {
        "id": 34,
        "text": "34.下列有關metoclopramide止吐作用的敘述，何者正確？",
        "options": {
            "A": "僅作用於中樞",
            "B": "僅為黏膜保護劑",
            "C": "同時具中樞與周邊作用",
            "D": "僅具制酸作用"
        },
        "image": null
    },
    {
        "id": 35,
        "text": "35.下列何者是臨床上使用的麻醉性鎮咳藥（narcotic antitussives）？",
        "options": {
            "A": "meperidine",
            "B": "hydrocodone",
            "C": "noscapine",
            "D": "dextromethorphan"
        },
        "image": null
    },
    {
        "id": 36,
        "text": "36.下列解充血劑（decongestants），何者不屬於histamine-receptor（H1）antagonists？",
        "options": {
            "A": "phenylephrine",
            "B": "dimenhydrinate",
            "C": "chlorpheniramine",
            "D": "hydroxyzine"
        },
        "image": null
    },
    {
        "id": 37,
        "text": "37.下列何者臨床上屬於鎮咳藥，但不會引起成癮性？",
        "options": {
            "A": "naloxone",
            "B": "dextromethorphan",
            "C": "meperidine",
            "D": "ipartropium"
        },
        "image": null
    },
    {
        "id": 38,
        "text": "38.下列藥物何者不具有氣管擴張作用？",
        "options": {
            "A": "theophylline",
            "B": "propranolol",
            "C": "atropine",
            "D": "isoproterenol"
        },
        "image": null
    },
    {
        "id": 39,
        "text": "39.下列何者在獸醫臨床上常被用於催產？",
        "options": {
            "A": "PGD2",
            "B": "PGE2",
            "C": "PGF2α",
            "D": "PGI2"
        },
        "image": null
    },
    {
        "id": 40,
        "text": "40.下列有關carprofen的敘述，何者錯誤？",
        "options": {
            "A": "對COX-1之抑制能力比對COX-2之抑制強100倍",
            "B": "可用於犬作為鎮痛及消除炎症之藥物",
            "C": "很少發生胃腸道潰瘍及出血",
            "D": "會增加肝臟及腎臟產生毒性之風險"
        },
        "image": null
    },
    {
        "id": 41,
        "text": "41.下列何種NSAIDs對cyclooxygenase及lipoxygenase均有抑制作用？",
        "options": {
            "A": "deracoxib",
            "B": "carprofen",
            "C": "phenybutazone",
            "D": "tepoxalin"
        },
        "image": null
    },
    {
        "id": 42,
        "text": "42.下列有關aspirin的敘述，何者錯誤？",
        "options": {
            "A": "對血小板的抑制作用為可逆性",
            "B": "為非選擇性的cyclooxygenase抑制劑",
            "C": "對腹部絞痛之治療不具效應",
            "D": "可被併用於治療敗血症及內毒素性休克重度感染的動物"
        },
        "image": null
    },
    {
        "id": 43,
        "text": "43.胰島素的分泌會受到下列何者的抑制？",
        "options": {
            "A": "glucagon",
            "B": "gastrin",
            "C": "epinephrine",
            "D": "secretin"
        },
        "image": null
    },
    {
        "id": 44,
        "text": "44.下列何者主要透過活化α-腎上腺素性受體，造成平滑肌持久之收縮？",
        "options": {
            "A": "ergonovine",
            "B": "finasteride",
            "C": "bromocriptine",
            "D": "flumethasone"
        },
        "image": null
    },
    {
        "id": 45,
        "text": "45.下列何者不屬於抗甲狀腺藥（antithyroid drugs）？",
        "options": {
            "A": "methimazole",
            "B": "carbimazole",
            "C": "albendazole",
            "D": "propylthiouracil"
        },
        "image": null
    },
    {
        "id": 46,
        "text": "46.牛產後麻痺與缺乏下列何者有關？",
        "options": {
            "A": "維生素D",
            "B": "銅",
            "C": "維生素A",
            "D": "生物素"
        },
        "image": null
    },
    {
        "id": 47,
        "text": "47.當豬隻缺乏維生素A時，下列何種障礙最顯著？",
        "options": {
            "A": "呼吸作用",
            "B": "繁殖性能",
            "C": "神經傳遞",
            "D": "消化功能"
        },
        "image": null
    },
    {
        "id": 48,
        "text": "48.下列何藥物可用於治療末期腎臟疾病所導致之貧血？",
        "options": {
            "A": "ferric sulfate",
            "B": "vitamin K",
            "C": "erythropoietin",
            "D": "vitamin B12"
        },
        "image": null
    },
    {
        "id": 49,
        "text": "49.Penciclovir以局部（topically）投藥，對下列何種病毒有效？",
        "options": {
            "A": "herpesvirus",
            "B": "cytomegalovirus",
            "C": "myxovirus",
            "D": "poxvirus"
        },
        "image": null
    },
    {
        "id": 50,
        "text": "50.下列何者主要是抑制病毒的脫殼（uncoating）？",
        "options": {
            "A": "zidovudine",
            "B": "amantadine",
            "C": "acyclovir",
            "D": "idoxuridine"
        },
        "image": null
    },
    {
        "id": 51,
        "text": "51.下列何者在犬隻消化道的吸收較其他三種藥品為佳？",
        "options": {
            "A": "neomycin",
            "B": "bacitracin",
            "C": "tubocurarine",
            "D": "enrofloxacin"
        },
        "image": null
    },
    {
        "id": 52,
        "text": "52.下列那一抗微生物藥物不可使用於乳牛之治療？",
        "options": {
            "A": "nitrofurazone",
            "B": "penicillin G",
            "C": "streptomycin",
            "D": "tetracycline"
        },
        "image": null
    },
    {
        "id": 53,
        "text": "53.下列那一種磺胺劑可製成中性酸鹼值之鈉鹽製劑而適用於眼科？",
        "options": {
            "A": "sulfamethazine",
            "B": "sulfacetamide",
            "C": "sulfadimethoxine",
            "D": "sulfachlorpyridazine"
        },
        "image": null
    },
    {
        "id": 54,
        "text": "54.下列那一種抗微生物之併用組合比較不會誘發細菌抗藥性之形成？",
        "options": {
            "A": "sulfathiazole-sulfaquinoxaline",
            "B": "sulfadiazine-sulfamethoxazole",
            "C": "sulfadiazine-trimethoprim",
            "D": "sulafasalazine-sulfaguanindine"
        },
        "image": null
    },
    {
        "id": 55,
        "text": "55.高劑量給予低溶解度的磺胺劑sulfathiazole所產生之主要不良反應為何？",
        "options": {
            "A": "結晶尿",
            "B": "過敏性胃腸炎",
            "C": "甲狀腺功能低下",
            "D": "低凝血酶元血症"
        },
        "image": null
    },
    {
        "id": 56,
        "text": "56.青黴素類抗生素抗菌活性的破壞，通常發生於其化學構造上的那一個位置被裂解之後所造成？",
        "options": {
            "A": "醯胺鍵",
            "B": "β-內醯胺環",
            "C": "羰基連接",
            "D": "羧基連接"
        },
        "image": null
    },
    {
        "id": 57,
        "text": "57.青黴素類抗生素之作用機制主要為抑制細菌那一成分之功能？",
        "options": {
            "A": "DNA gyrase",
            "B": "RNA polymerase",
            "C": "thymidylate synthase",
            "D": "transpeptidase"
        },
        "image": null
    },
    {
        "id": 58,
        "text": "58.下列那一藥物屬於長效型青黴素類製劑，單一次肌肉注射後其吸收可以維持48~72小時？",
        "options": {
            "A": "benzathine penicillin G",
            "B": "procaine penicillin G",
            "C": "benzylpenicillin",
            "D": "ampicillin"
        },
        "image": null
    },
    {
        "id": 59,
        "text": "59.第一代頭孢菌素類（cephalosporins）藥物經吸收後，下列那一組織無法滲入？",
        "options": {
            "A": "尿液",
            "B": "乳液",
            "C": "皮下組織",
            "D": "腦脊髓液"
        },
        "image": null
    },
    {
        "id": 60,
        "text": "60.長時間或高劑量使用頭孢菌素類（cephalosporins）藥物，對動物最可能產生之不良反應為何？",
        "options": {
            "A": "腎結晶尿",
            "B": "中樞神經性痙攣",
            "C": "神經肌肉連接阻斷",
            "D": "骨髓抑制"
        },
        "image": null
    },
    {
        "id": 61,
        "text": "61.下列那一藥物注射給藥後對腦脊髓液之穿透力最好？",
        "options": {
            "A": "cephalexin",
            "B": "aztreonem",
            "C": "gentamicin",
            "D": "azithromycin"
        },
        "image": null
    },
    {
        "id": 62,
        "text": "62.Aminoglycosides引起之神經肌肉阻斷不良反應，與抑制神經突觸下列何者的釋出較有關？",
        "options": {
            "A": "serotonin",
            "B": "catecholamine",
            "C": "epinephrine",
            "D": "acetylcholine"
        },
        "image": null
    },
    {
        "id": 63,
        "text": "63.Lincosamides易造成下列那一動物腹瀉，因而限制使用？",
        "options": {
            "A": "牛",
            "B": "馬",
            "C": "貓",
            "D": "豬"
        },
        "image": null
    },
    {
        "id": 64,
        "text": "64.由長春花（periwinkle）植物中萃取得到的抗腫瘤藥物是：",
        "options": {
            "A": "paclitaxel",
            "B": "etoposide",
            "C": "irinotecan",
            "D": "vinblastine"
        },
        "image": null
    },
    {
        "id": 65,
        "text": "65.下列何種抗腫瘤藥物結構類似葉酸？",
        "options": {
            "A": "mechlorethamine",
            "B": "methotrexate",
            "C": "mitoxantrone",
            "D": "mitotane"
        },
        "image": null
    },
    {
        "id": 66,
        "text": "66.下列何者不屬於aminoglycoside類抗生素？",
        "options": {
            "A": "apramycin",
            "B": "tobramycin",
            "C": "paromomycin",
            "D": "tulathromycin"
        },
        "image": null
    },
    {
        "id": 67,
        "text": "67.飼料中若葉酸添加劑量過高，則會降低下列何種藥物的抗菌效果？",
        "options": {
            "A": "aminoglycosides",
            "B": "sulfonamides",
            "C": "licosamides",
            "D": "tetracyclines"
        },
        "image": null
    },
    {
        "id": 68,
        "text": "68.下列何者可用於治療犬隻之G（+）所引起的牙周病及新孢子蟲病（neosporosis）？",
        "options": {
            "A": "clindamycin",
            "B": "erythromycin",
            "C": "methicillin",
            "D": "tylosin"
        },
        "image": null
    },
    {
        "id": 69,
        "text": "69.下列何者不是用於治療犬毛囊蟲症？",
        "options": {
            "A": "ivermectin",
            "B": "amitraz",
            "C": "famotidine",
            "D": "doramectin"
        },
        "image": null
    },
    {
        "id": 70,
        "text": "70.臨床上，鸚鵡嗉囊分離出念珠菌，下列何者不是治療用藥？",
        "options": {
            "A": "flucytosine",
            "B": "nystatin",
            "C": "ketoconazole",
            "D": "gemcitabine"
        },
        "image": null
    },
    {
        "id": 71,
        "text": "71.下列何者為azoles類抗黴菌機制？",
        "options": {
            "A": "藉由結合真菌原生質體膜麥角固醇，因而改變細胞的滲透性",
            "B": "藉由結合真菌微管防止主軸的形成而抑制有絲分裂",
            "C": "藉由結合真菌的thymidylate synthase，抑制DNA合成",
            "D": "藉由阻斷細胞素P450酵素抑制麥角固醇的合成，因而提高細胞的滲透性"
        },
        "image": null
    },
    {
        "id": 72,
        "text": "72.Azithromycin可用於治療下列何種疾病？",
        "options": {
            "A": "耳疥癬",
            "B": "隱孢子蟲症",
            "C": "山羊蟯蟲症",
            "D": "豬鉤頭蟲症"
        },
        "image": null
    },
    {
        "id": 73,
        "text": "73.糞便檢出馬蛔蟲（Parascaris sp.）蟲卵，可用下列何者驅除之？",
        "options": {
            "A": "glipizide",
            "B": "propantheline",
            "C": "metaflumizone",
            "D": "oxfendazole"
        },
        "image": null
    },
    {
        "id": 74,
        "text": "74.下列何者可激活麩氨酸閘門的氯離子通道（glutamate-gated chloride channels），因此抑制線蟲（及節肢動物）的神經傳遞，誘導鬆弛性麻痺，也能夠活化γ-胺基丁酸（GABA）閘門的氯離子通道？",
        "options": {
            "A": "morantel",
            "B": "albendazole",
            "C": "levamisole",
            "D": "ivermectin"
        },
        "image": null
    },
    {
        "id": 75,
        "text": "75.能活化線蟲乙醯膽鹼受體，造成痙攣而麻痺的藥物為：",
        "options": {
            "A": "piperazine",
            "B": "levamisole",
            "C": "ivermectin",
            "D": "milbemycin"
        },
        "image": null
    },
    {
        "id": 76,
        "text": "76.Thiabendazole抗蟲的藥理作用機制主要為：",
        "options": {
            "A": "促進fumarate reductase之效能",
            "B": "打開GABA-gated-chloride channel",
            "C": "結合線蟲的tubulin",
            "D": "活化尼古丁型乙醯膽鹼受體"
        },
        "image": null
    },
    {
        "id": 77,
        "text": "77.動物有機磷中毒，除需投予atropine外，還需補充下列何者以回復acetylcholine esterase活性？",
        "options": {
            "A": "dimercaprol",
            "B": "pralidoxime",
            "C": "calcium disodium EDTA",
            "D": "sodium thiosulfate"
        },
        "image": null
    },
    {
        "id": 78,
        "text": "78.畜舍中散發出「腐敗的雞蛋味」的氣體，對呼吸道黏膜具強烈刺激性，其成分為：",
        "options": {
            "A": "H2S",
            "B": "CH4",
            "C": "NH3",
            "D": "HCN"
        },
        "image": null
    },
    {
        "id": 79,
        "text": "79.下列有關動物用藥殘留之敘述，何者正確？",
        "options": {
            "A": "殘留容許量係指該藥物原體（parent compound）之含量",
            "B": "有登記證的動物用藥，都必須訂定動物用藥殘留標準",
            "C": "不得檢出的動物用藥品目，食品中的藥物含量為零",
            "D": "訂定動物用藥殘留標準，主要為行政裁量之管制標準"
        },
        "image": null
    },
    {
        "id": 80,
        "text": "80.下列何種成分對大多數動物具強烈肝毒性？",
        "options": {
            "A": "strychnine",
            "B": "pyrrolizidine",
            "C": "oxalate",
            "D": "nitrate"
        },
        "image": null
    }
]